ABSTRACT
INTRODUCTION
Maintenance of primary dentition is imperative for the development of arch form, esthetics, function, mastication and normal eruption of permanent DOI: 10.12982/CMUJNS.2013.0012 teeth. Premature loss, especially of the primary second molar, can cause various problems. This usually results in mesial eruption of the first permanent molars and causes subsequent problems such as ectopic eruption of the second premolar, space loss for the successor permanent teeth, alterations in speech and impairment of function (AAPD, 2010 (AAPD, -2011 . Therefore, decayed primary teeth should be treated whenever possible. However, infected teeth with gross loss of tooth structure, lack of adequate bone support, excessive pathologic root resorption, advanced internal or external resorption, furcation involvement or periapical infection involving the crypt of the succedaneous tooth should be considered for extraction (Fuk, 2005; Sari and Okte, 2008; AAPD, 2010 AAPD, -2011 .
In non-vital primary teeth for which extraction is not the aim, pulpectomy is generally recommended as a treatment of choice. The procedure involves removing coronal and radicular pulp tissues, debridement, enlargement and filling the root canal with intracanal medicament (AAPD, 2010 (AAPD, -2011 . The ideal intracanal medicament for pulpectomy in primary teeth should have the following properties: easily fill the root canal, be antiseptic, resorb at a similar rate as the primary root, not harm the periapical tissue and permanent tooth germ, resorb readily if extruded beyond the apex, adhere to root canal walls, not shrink, be radiopaque, and not discolor the tooth (Mortazavi and Mesbahi, 2004; Fuk, 2005; Ozalp et al., 2005) . However, while no single material meets all the requirements of an ideal intracanal medicament for a primary tooth (Mortazavi and Mesbahi, 2004; Fuk, 2005; Ozalp et al., 2005) , Vitapex ® , a premixed calcium hydroxide and iodoform paste, comes close. Many authors have reported favorable results with Vitapex ® , with success rates from 96% to 100% (Nurko and Garcia-Godoy, 1999; Mortazavi and Mesbahi, 2004; Ozalp et al., 2005; Nakornchai et al., 2010) . Vitapex ® is biocompatible, rapidly resorbs when extruded beyond the apex and is easily removed if retreatment is needed. However, its rapid resorption may reduce its antibacterial properties and lower its disinfection properties compared to other root canal filling materials (Nakornchai et al., 2010) .
Lesion Sterilization and Tissue Repair Therapy (LSTR), or Non Instrumental Endodontic Treatment (NIET), is a new biological approach for non-vital pulp treatment. This procedure has no mechanical instrumentation; thus, prevents over enlargement of root canal and unnecessary irritation of periapical tissue (Takushige et al., 2004; Nakornchai et al., 2010; Handajani et al., 2010) . This procedure uses a mixture of three antibacterial drugs (3Mix MP) as a root canal medicament to eliminate the remaining bacteria in endodontic lesions. The medicament consists of metronidazole, ciprofloxacin and minocycline -with macrogol (M) as the ointment base and propylene glycol (P) as the carrier (Takushige et al., 2004; Handajani et al., 2010) . The short-term success of 3Mix MP in non-vital pulp treatment in primary teeth has been reported in some studies. Many authors have reported favorable results of 3Mix MP with success rates from 83% to 100% (Takushige et al., 2004; Alam et al., 2005; Handajani et al., 2010; Nakornchai et al., 2010) . However, the success of this treatment over longer follow-up periods has not yet been reported.
Various factors affect the outcome of non-vital pulp treatment. These factors consist of diagnosis and pathologic conditions of the tooth prior to the treatment, types of non-vital pulp treatment and medicaments, irrigants, temporary materials and permanent restorations (Sjogren et al., 1990) . Nevertheless, few have studied the factors influencing success in primary teeth with non-vital pulp treatment. We, therefore, were interested in studying the long-term success rate of non-vital pulp treatment in primary teeth, particularly with Vitapex ® and 3Mix MP medicaments. We also wanted to clarify further the relationship between the above factors and the success rate of non-vital pulp treatment.
MATERIALS AND METHODS
This study was approved by the Research Ethics Committee of the Faculty of Dentistry, Chiang Mai University, Thailand. The dental records of patients at the Pediatric Dentistry Clinic, Faculty of Dentistry, Chiang Mai University that had non-vital pulp treatments with Vitapex ® or 3Mix MP in primary teeth from January 2005 to May 2011 were used for this study. If the records met the inclusion criteria, the patients were called back for follow-up.
The clinical and radiographic inclusion criteria were: (1) history of non-vital pulp treatment with Vitapex ® or 3Mix MP; (2) absence of a systemic disease; (3) dental records included adequate information (diagnosis, medicaments, irrigants, temporary materials and permanent restorations, at the minimum); (4) dental records had pre-operative and recall radiographs for assessing at least 6 months of follow-up. The criteria for clinical and radiographic success are shown in Table 1 . Teeth were considered a clinical success if they met all of the clinical success criteria. Teeth were considered a radiographic success if they met one of the radiographic success criteria. All teeth were assessed by one examiner. Intraexaminer reliability of radiographic evaluation was calculated by Cohen's kappa statistic, which indicated an acceptable agreement of 0.97.
The demographic data and factors that may affect success rate were recorded. The follow-up periods were divided into six groups: (1) >6-12 months; (2) >12-24 months; (3) >24-36 months; (4) >36-48 months; (5) >48-60 months; (6) >60-72 months. The data obtained was analyzed by descriptive statistics.
RESULTS
A total of 73 primary teeth that had non-vital pulp treatment either by Vitapex ® pulpectomy or 3Mix MP therapy were identified as meeting the study criteria. Fifty-two healthy children, aged between 3 to 10 years (mean age=4.4 years), participated in this study. Demographic data of the patients is shown in Table 2 . Distribution of teeth according to the follow-up period is shown in Table 3 . Note: N= number of total treated teeth in the LSTR with 3Mix MP group. n= number of treated teeth that were determined as success in the LSTR with 3Mix MP group.
This study examined the clinical and radiographic success rates of Vitapex ® and 3Mix MP for non-vital pulp treatment in long-term follow-up and revealed high clinical success rate and fairly high radiographic success rate of both treatments (Table 4 and 5) .
Including all follow-up periods (from 6 to 72 months), the overall success rates of the Vitapex ® group as determined by clinical and radiographic evaluations were 89.0% and 64.6%, respectively. The success rates of the 3Mix MP group as determined by clinical and radiographic evaluations were 84.6% and 65.2%, respectively. No statistically significant difference was found between the two groups.
We noted some treatment failures from both treatments as detailed in Tables  6 and 7 . 
DISCUSSION
In the present study, Vitapex ® , medicament for pulpectomy procedure, gave a high clinical success rate at 12-24 months (95.7%) that was close to the previous prospective studies (Nurko and Garcia-Godoy, 1999; Mortazavi and Mesbahi, 2004; Ozalp et al., 2005; Trairatvorakul and Chunlasikaiwan, 2008; Nakornchai et al., 2010) and the retrospective study (Sirimaharaj and Sinsoontorn, 2008) , which reported clinical success rates of 96-100% at 12-22 months
Group of follow-up period* Failure findings
Group of follow-up period* Failure findings of follow-up. Regarding the radiographic success, the pulpectomy with Vitapex ® group showed a high radiographic success rate at 12-24 months (87.0%). This was lower than that of Trairatvorakul and Chunlasikaiwan (2008) , which showed radiographic success rate of 89%, as well as the studies of Ozalp et al., (2005) and Nurko and Garcia-Godoy (1999) , which showed radiographic success rate of 100%. However, the results of this study were higher than that of Nakornchai et al., (2010) , which showed a radiographic success rate of 56% at 12-months follow-up. The fairly low radiographic success of the latter study may possibly be due to the sample selection, since only teeth with a poor prognosis were selected for the study (Nakornchai et al., 2010) .
LSTR 3Mix therapy also showed a high clinical success rate at 12-24 months (90.9%), but lower than the studies of Takushige et al., (2004) , Prabhakar et al., (2008) , and Nakornchai et al., (2010) , which reported clinical success rates of 96-100% at follow-up periods from 12-20 months. This present study also found that clinical success rates of the LSTR 3Mix therapy group tended to decrease in long-term follow-up, similar to the study of Trairatvorakul and Detsomboonrat (2011) . Regarding the radiographic success, the LSTR 3Mix therapy group showed a fairly high radiographic success rate at 12-24 months (72.7%) that was lower than that of Prabhakar et al., (2008) (76.7%) and Nakornchai et al., (2010) (76%) at the 12-month follow-up period. In the present study, 84.1% of the samples in the LSTR 3Mix therapy group were teeth with a poor prognosis, similar to those from Nakornchai et al., (2010) . The radiographic success in this present study was higher than the study of Trairatvorakul and Detsomboonrat (2011), which reported only 36.7% radiographic success at 24-27 months follow-up. The differences in study designs, sample sizes and treatment procedures may influence these different results.
Nevertheless, failed cases of the Vitapex ® and 3Mix MP groups were found, using both the clinical and radiographic criteria. We found failures in the Vitapex ® and 3Mix MP groups that presented with the leakage of temporary filling in two visits-non-vital pulp treated teeth and the deterioration and leakage of permanent restoration, such as composite resin or glass ionomer cement. These factors can lead to bacterial penetration (Anderson et al., 1990; Demarco et al., 2005; Qvist et al., 2010) . Thus, the influence of various permanent restorations and the time elapsed between the temporary and permanent restorations were found to be relevant to the success of non-vital pulp treatment in primary teeth.
From this study, both pulpectomy with Vitapex ® and LSTR therapy with 3Mix MP showed acceptable success rates. It seems that LSTR therapy with 3Mix MP may be appropriate for treatment of poor prognosis cases or cases for which mechanical instrumentation could not be achieved due to physiologic root resorption (Takushige et al., 2008) .
